The aim of the research group is to improve care in all points of the stroke treatment chains. All projects should have direct implications for clinical practice.
Appleton JP, Woodhouse LJ, Anderson CS, Ankolekar S, Cala L, Dixon M, England TJ, Krishnan K, Mair G, Muir KW, Potter J, Price CI, Randall M, Robinson TG, Roffe C, Sandset EC, Saver JL, Shone A, Siriwardena AN, Wardlaw JM, Sprigg N, Bath PM, RIGHT-2 Investigators(2024) Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trial Stroke Vasc Neurol, 9(1), 38-49 DOI 10.1136/svn-2022-001634, PubMed 37290930
Christensen E, Fagerheim Bugge H, Hagemo J, Larsen K, Harring AK, Gleditsch J, Ibsen J, Guterud M, Sandset EC, Hov MR(2024) Prehospital stroke diagnostics using three different simulation methods: A pragmatic pilot study Eur Stroke J, 23969873241252564(in press) DOI 10.1177/23969873241252564, PubMed 38751332
Connolly SJ, Sharma M, Cohen AT, Demchuk AM, Członkowska A, Lindgren AG, Molina CA, Bereczki D, Toni D, Seiffge DJ, Tanne D, Sandset EC, Tsivgoulis G, Christensen H, Beyer-Westendorf J, Coutinho JM, Crowther M, Verhamme P, Amarenco P, Roine RO, Mikulik R, Lemmens R, Veltkamp R, Middeldorp S, Robinson TGet al.(2024) Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage N Engl J Med, 390(19), 1745-1755 DOI 10.1056/NEJMoa2313040, PubMed 38749032